The joint study revealed that it’s the eye pressure that compounds the inflammation by activating a protein that works against microbial infections. Research co-author Dr. Zhang Kang says that the anti-microbial protein also kills cells in the retina. The only treatment seen to inhibit the eye’s production of these substances at present is a drug that’s already undergoing tests for cancer and stroke patients.
http://www.nceent.com/seeking-eye-doctor-durham-nc-glaucoma-solutions/
No comments:
Post a Comment